Balance Sheet
Cash Flow Statement
Amortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ingevity (NGVT) Gains from Investment Securities (2016 - 2025)

Ingevity (NGVT) has disclosed Gains from Investment Securities for 11 consecutive years, with -$3.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Gains from Investment Securities fell 114.48% to -$3.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$4.6 million, a 119.91% decrease, with the full-year FY2024 number at $26.9 million, up 13350.0% from a year prior.
  • Gains from Investment Securities was -$3.2 million for Q3 2025 at Ingevity, up from -$4.2 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $22.1 million in Q3 2024 to a low of -$28.9 million in Q3 2021.
  • A 5-year average of $1.8 million and a median of $2.0 million in 2021 define the central range for Gains from Investment Securities.
  • Peak YoY movement for Gains from Investment Securities: surged 870.59% in 2021, then crashed 290.91% in 2025.
  • Ingevity's Gains from Investment Securities stood at $4.3 million in 2021, then crashed by 48.84% to $2.2 million in 2022, then crashed by 140.91% to -$900000.0 in 2023, then skyrocketed by 422.22% to $2.9 million in 2024, then plummeted by 210.34% to -$3.2 million in 2025.
  • Per Business Quant, the three most recent readings for NGVT's Gains from Investment Securities are -$3.2 million (Q3 2025), -$4.2 million (Q2 2025), and -$100000.0 (Q1 2025).